There is general agreement that the U.S. health care system has issues, but there isn’t consensus on what exactly needs to be done to fix those issues. A new report published by Trilliant Health, an economic analysis company, points out some notable trends that should be given the attention they deserve by health care system stakeholders.
The authors indicate in the report that by 2033, the share of GDP going into health care costs will climb to 20.3%. On the surface, this may look like increasing amounts of resources are going to be channeled into health care and this would be to the benefit of the population. However, the report makes an indicting assessment that says it is becoming increasingly apparent from available data that health care system outputs are far below the inputs. In other words, the money going into health care isn’t translating into the desired outcomes.
Allison Oakes, the Chief Research Officer at Trilliant Health, stated in a press release that the health care system of the U.S. has increasingly become flooded with profit-seeking entities engaged in treating people. For those firms, Oakes says, profit comes first and the businesses have no interest in promoting health unless their undertakings will benefit the companies’ bottom lines.
A notable trend that the report draws attention to regards the nature of services that people are seeking from health care providers. Using data from 2024, the authors say services linked to behavioral health have seen a 43.7% uptick in the years 2018-2024 while visits for primary health care saw a drop of 7.3% within that timeframe. This means that fewer people are visiting medical care facilities to obtain primary health care, and that is worrying.
Another observation pointed out could shed some light on why primary health care is lagging behavioral health care services. In the report, the authors indicate that nearly three-quarters of the counties within the United States are designated as having a shortage of professionals offering primary health care services. If there aren’t enough professionals for people to visit, then it may naturally follow that visits intended to obtain primary health care services will decline.
The costs of medical care have jumped 54.5% since 2009, and yet general consumer prices have seen a lower growth level of 45.7%. This means more people are finding it harder to meet their medical care costs, and high medical debt has become a painful reality for many families. While entities like Astiva Health may be doing the best they can to offer medical insurance policies geared at ensuring racial minorities in their areas of operation can get affordable medical care, the challenges are vast and require system-wide reforms so that American health care works better.
NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
